Add Row 
Add 
Has the UK’s Brexit Reset Halted CBD Progress?
The UK CBD industry has long aimed to secure regulatory approval, only to find its journey potentially derailed by EU alignment discussions. As the Food Standards Agency (FSA) recently hinted, the future of this arduous path is uncertain, with industry stakeholders grappling with what this means for the future of CBD in the UK.
The Regulatory Journey
Over the past five years, the UK has dedicated significant resources towards building a bespoke regulatory framework for CBD, the only one of its kind globally. It began with 15 applications for food authorisation that had passed initial safety assessments, marking what many viewed as pioneering progress towards fully integrating CBD into the food supply. However, the journey has faced numerous obstacles, most notably delays and regulatory bottlenecks that have crippled companies within the sector.
Impact of Brexit and EU Alignment
In light of ongoing negotiations for a Sanitary and Phytosanitary (SPS) agreement with the EU, the FSA is re-evaluating its priorities. According to internal discussions from a closed board meeting in December 2025, which became public in early March 2026, the FSA chair expressed doubts about the likelihood of authorisations being issued before the SPS agreement is finalized. With potential alignment to EU standards, the EU’s drastically lower safe intake limit for CBD sets another hurdle for British producers.
Crossing Converging Deadlines
Crucial deadlines loom over the CBD industry in the UK. A public consultation regarding three CBD applications is set to conclude in June 2026, alongside the expected finalisation of the SPS agreement. This would allow for necessary ministerial recommendations, yet many industry insiders remain skeptical that these authorisations will materialize in time. As Professor Susan Jebb, the FSA chair warned, time is running out, and 'frozen market' concerns highlight the challenges ahead.
A Community Impact
The implications of this regulatory impasse are felt deeply within local communities and businesses across the UK. Small businesses identifying as innovators face an uphill battle to comply with the evolving landscape, and for many, securing a foothold in this space is less about business and more about survival. Local livelihoods depend on the success of such initiatives, and the delay in authorizations threatens to stifle the CBD market just as it begins to emerge.
Looking Ahead: Predictions and Opportunities
As stakeholders in the CBD industry reflect on the challenges posed by Brexit and regulatory delays, the future remains uncertain. However, this period may also present an opportune moment for clear advocacy and better alignment with governmental bodies. Clear communication strategies tailored towards law-makers and stakeholders can ensure that the voices of small business owners, producers, and consumers are heard in future discussions.
For those in the cannabis industry, the onus is on community engagement along with lobbying efforts to shape future regulatory outcomes. It becomes imperative to convey the fundamental value of the CBD industry to local economies and health sectors.
This situation emphasizes the need for continued dialogue and grassroots activism within the cannabis community. Understanding and acting upon the intricacies of these regulatory frameworks can be crucial as the landscape evolves. It’s a time for unity and perseverance, both from business leaders and consumers who believe in the potential of CBD.
Take Action for Positive Change
Now is the time to engage actively in conversations around CBD regulation. Share your insights and concerns with local representatives and industry groups. Advocate for the much-needed clarity and fairness in CBD regulations, as the future of this promising industry depends on informed and united voices. Together, we can influence the path forward.
Write A Comment